These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans. Kirkpatrick MG; Gunderson EW; Levin FR; Foltin RW; Hart CL Psychopharmacology (Berl); 2012 Jan; 219(1):191-204. PubMed ID: 21748253 [TBL] [Abstract][Full Text] [Related]
4. A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Kirkpatrick MG; Gunderson EW; Perez AY; Haney M; Foltin RW; Hart CL Psychopharmacology (Berl); 2012 Jan; 219(1):109-22. PubMed ID: 21713605 [TBL] [Abstract][Full Text] [Related]
5. Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance. Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR Drug Alcohol Depend; 2011 Dec; 119(3):187-93. PubMed ID: 21737214 [TBL] [Abstract][Full Text] [Related]
6. Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work. Hart CL; Ward AS; Haney M; Nasser J; Foltin RW Psychopharmacology (Berl); 2003 Aug; 169(1):42-51. PubMed ID: 12734635 [TBL] [Abstract][Full Text] [Related]
7. Effects of intranasal methamphetamine on metacognition of agency. Kirkpatrick MG; Metcalfe J; Greene MJ; Hart CL Psychopharmacology (Berl); 2008 Mar; 197(1):137-44. PubMed ID: 18043908 [TBL] [Abstract][Full Text] [Related]
14. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance. Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503 [TBL] [Abstract][Full Text] [Related]
15. Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine. Reynolds AR; Strickland JC; Stoops WW; Lile JA; Rush CR Drug Alcohol Depend; 2017 Dec; 181():25-29. PubMed ID: 29028556 [TBL] [Abstract][Full Text] [Related]
16. Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study. Johnson BA; Roache JD; Bordnick PS; Ait-Daoud N Psychopharmacology (Berl); 1999 Jun; 144(3):295-300. PubMed ID: 10435398 [TBL] [Abstract][Full Text] [Related]
17. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine. Marks KR; Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR J Clin Psychopharmacol; 2016 Jun; 36(3):213-21. PubMed ID: 27043121 [TBL] [Abstract][Full Text] [Related]
18. The effects of transnasal butorphanol on mood and psychomotor functioning in healthy volunteers. Zacny JP; Lichtor JL; Klafta JM; Alessi R; Apfelbaum JL Anesth Analg; 1996 May; 82(5):931-5. PubMed ID: 8610901 [TBL] [Abstract][Full Text] [Related]
19. Effects of a Serotonin 2C Agonist and a 2A Antagonist on Actigraphy-Based Sleep Parameters Disrupted by Methamphetamine Self-Administration in Rhesus Monkeys. Perez Diaz M; Andersen ML; Rice KC; Howell LL Neuropsychopharmacology; 2017 Jun; 42(7):1531-1538. PubMed ID: 27986974 [TBL] [Abstract][Full Text] [Related]
20. Morning administration of oral methamphetamine dose-dependently disrupts nighttime sleep in recreational stimulant users. Herrmann ES; Johnson PS; Bruner NR; Vandrey R; Johnson MW Drug Alcohol Depend; 2017 Sep; 178():291-295. PubMed ID: 28686987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]